Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

AstraZeneca’s Truqap plus Faslodex receives FDA approval for advanced breast cancer

About 290,000 people in the US will be diagnosed with breast cancer in 2023

- PMLiVE

National surveillance data reveals increase in antibiotic resistant infections in England

The number of deaths due to severe antibiotic resistant infections also increased in 2022

- PMLiVE

Connected devices: key considerations for pharmaceutical companies

How the use of data from connected drug delivery devices could help transform clinical trials

Let everyone have a say; the top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #7. Everyone Gets a Say Another top benefit for the...

Impetus Digital

- PMLiVE

Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market

Authored by: Marc Garcia and Tania Rodrigues

Inizio

- PMLiVE

Bristol Myers Squibb’s lung cancer drug Augtyro receives FDA approval

The drug was added to BMS’ portfolio last year through its $4.1bn acquisition of Turning Point

- PMLiVE

Kite and Arcellx expand cell therapy partnership in deal worth over $285m

The companies' existing CART-ddBCMA collaboration now covers lymphomas

- PMLiVE

MHRA authorises world-first gene therapy for two inherited blood disorders

Casgevy is now the first licensed treatment that uses the gene-editing tool CRISPR

- PMLiVE

How to maintain employee engagement for those working remotely

By Jayne Carey-George and Vic Harvey

COUCH Health publishes report to encourage patient engagement in the MedTech sector

Manchester, UK, 27 February 2023 — COUCH Health today announced the publication of a new report “The Power of Patient Engagement in MedTech”.

COUCH Health

- PMLiVE

Novartis gains global rights to Legend’s CAR-T cell therapies in deal worth over $1bn

Novartis can apply its T-Charge platform to the manufacturing process of the therapies

- PMLiVE

New genetic variants linked to prostate cancer in men with African ancestry

A dataset was compiled for the research containing DNA from over 944,000 men

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links